Supplemental material
Journal of Drug Assessment
Volume 8, 2019 - Issue 1
Related Research Data
Efficacy and safety of alfimeprase in patients with acute peripheral arterial occlusion (PAO)
Source:
Elsevier BV
A first-in-human phase I trial of locally delivered human plasmin for hemodialysis graft occlusion
Source:
Wiley-Blackwell
Phase 2, randomized, open-label study on catheter-directed thrombolysis with plasmin versus rtPA and placebo in acute peripheral arterial occlusion
Source:
Taylor & Francis
Phase 2, randomized, open-label study on catheter-directed thrombolysis with plasmin versus rtPA and placebo in acute peripheral arterial occlusion
Source:
Taylor & Francis
A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia
Source:
Elsevier BV
Thrombolytic potency of acid-stabilized plasmin: superiority over tissue-type plasminogen activator in an in vitro model of catheter-assisted thrombolysis
Source:
Wiley-Blackwell
On the specific interaction between the lysine-binding sites in plasmin and complementary sites in α2-antiplasmin and in fibrinogen
Source:
Elsevier BV
Phase 1 study of human plasma-derived plasmin (TAL-05-00018) in hemodialysis graft occlusion
Source:
Elsevier BV
Safety of catheter-delivered plasmin in patients with acute lower extremity arterial or bypass graft occlusion: phase I results
Source:
Wiley-Blackwell
Thrombolysis in the Management of Lower Limb Peripheral Arterial Occlusion—A Consensus Document
Source:
Elsevier BV
Results of a Prospective Randomized Trial Evaluating Surgery Versus Thrombolysis for Ischemia of the Lower Extremity The STILE Trial
Source:
Ovid Technologies (Wolters Kluwer Health)
Phase 2, randomized, open-label study on catheter-directed thrombolysis with plasmin versus rtPA and placebo in acute peripheral arterial occlusion
Source:
Taylor & Francis
Distinct dose-dependent effects of plasmin and TPA on coagulation and hemorrhage
Source:
American Society of Hematology
On the Regulation and Control of Fibrinolysis
Source:
Georg Thieme Verlag KG
Thrombolysis or peripheral arterial surgery: Phase I results
Source:
Elsevier BV
Quality Improvement Guidelines for Percutaneous Management of Acute Lower-extremity Ischemia
Source:
Elsevier BV
A Comparison of Recombinant Urokinase with Vascular Surgery as Initial Treatment for Acute Arterial Occlusion of the Legs
Source:
Massachusetts Medical Society
Complications Associated with the Use of Urokinase and Recombinant Tissue Plasminogen Activator for Catheter-directed Peripheral Arterial and Venous Thrombolysis
Source:
Elsevier BV
Plasmin Induces Local Thrombolysis without Causing Hemorrhage: A Comparison with Tissue Plasminogen Activator in the Rabbit
Source:
Georg Thieme Verlag KG
Safety of Thrombolytic Therapy with Urokinase or Recombinant Tissue Plasminogen Activator for Peripheral Arterial Occlusion:A Comprehensive Compilation of Published Work
Source:
International Society of Endovascular Specialists
Direct fibrinolytic agents
Source:
Wiley
Linking provided by
